In the BioHarmony Drug Report Database
[Case Study: Key COVID-19 Drugs]
Includes access to the therapeutics reference in our “Combination Therapies for COVID-19 and Implications for Drug Safety” case study.
For a limited time, we are offering a free 30-day trial of this data set. Simply add it to your cart and follow the checkout process (no credit card information required).
The [Key COVID-19 Drugs] data set includes 10 drug reports:
- Azithromycin
- Chloroquine
- Dexamethasone
- Favipiravir
- Hydroxychloroquine
- Ivermectin
- Lopinavir
- Remdesivir
- Ritonavir
- Tocilizumab
One example of an included drug report data is shown below for Veklury.
Trade Name
|
Veklury |
|---|---|
Common Name
|
remdesivir |
ChEMBL ID
|
CHEMBL4065616 |
Indication
|
coronavirus, coronavirus infections, virus diseases |
Drug Class
|
Antivirals: adenosine analogs acting as RNA polymerase inhibitors |
Image (chem structure or protein)